ZA201701510B - Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin - Google Patents

Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin

Info

Publication number
ZA201701510B
ZA201701510B ZA2017/01510A ZA201701510A ZA201701510B ZA 201701510 B ZA201701510 B ZA 201701510B ZA 2017/01510 A ZA2017/01510 A ZA 2017/01510A ZA 201701510 A ZA201701510 A ZA 201701510A ZA 201701510 B ZA201701510 B ZA 201701510B
Authority
ZA
South Africa
Prior art keywords
skin
treating
barrier function
induced loss
topical
Prior art date
Application number
ZA2017/01510A
Other languages
English (en)
Inventor
L Meyskens Frank Jr
W Dellinger Ryan
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of ZA201701510B publication Critical patent/ZA201701510B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
ZA2017/01510A 2014-09-04 2017-02-28 Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin ZA201701510B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462046068P 2014-09-04 2014-09-04
PCT/US2015/048422 WO2016036999A1 (en) 2014-09-04 2015-09-03 Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin

Publications (1)

Publication Number Publication Date
ZA201701510B true ZA201701510B (en) 2018-11-28

Family

ID=55436471

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2017/01510A ZA201701510B (en) 2014-09-04 2017-02-28 Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin

Country Status (11)

Country Link
US (1) US9980924B2 (enExample)
EP (1) EP3194032B1 (enExample)
JP (1) JP2017525738A (enExample)
KR (1) KR20170045343A (enExample)
CN (1) CN107106877A (enExample)
AU (1) AU2015311799A1 (enExample)
BR (1) BR112017004304B1 (enExample)
CA (1) CA2959756C (enExample)
MX (1) MX375612B (enExample)
WO (1) WO2016036999A1 (enExample)
ZA (1) ZA201701510B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015311799A1 (en) 2014-09-04 2017-03-30 The Regents Of The University Of California Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin
WO2018034328A1 (ja) * 2016-08-17 2018-02-22 香港友池有限公司 プテロスチルベン配糖体を含む外用組成物
JP7061766B2 (ja) * 2017-09-20 2022-05-02 学校法人同志社 Ｄｊ－１タンパク質産生促進用組成物
KR20220123067A (ko) 2019-12-30 2022-09-05 로단 앤드 필즈, 엘엘씨 Ppar 작용제 복합물 및 사용 방법
EP4029496A1 (en) * 2021-01-18 2022-07-20 Universitat de València Pterostilbene and silibinin for preventing, ameliorating or reducing radiation-induced diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820975B1 (fr) * 2001-02-21 2004-03-12 Oreal Composition pour application topique comprenant au moins un hydroxystilbene et au moins un polyol pour solubiliser l'hydroxystilbene
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US8703161B2 (en) 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
US20100240767A1 (en) * 2009-03-23 2010-09-23 Muhammed Majeed Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof
EP2322159A1 (en) * 2009-10-30 2011-05-18 Green Molecular, S.L. Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic
US8841350B2 (en) * 2011-05-11 2014-09-23 ChromaDex Inc. Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
JP2013075851A (ja) * 2011-09-30 2013-04-25 Fujifilm Corp 皮膚外用剤
US20130296440A1 (en) 2012-05-01 2013-11-07 ChromaDex Inc. Pterostilbene and curcumin combination for treatment of oxidative stress and inflammation
CN103239540B (zh) * 2013-04-03 2014-11-12 广东药学院 一种凉血愈伤方提取物及治疗皮肤烧伤的复方白藜芦醇凉血愈伤油制剂
AU2015311799A1 (en) 2014-09-04 2017-03-30 The Regents Of The University Of California Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin
WO2016037007A1 (en) 2014-09-04 2016-03-10 The Regents Of The University Of California Topical pterostilbene compositions for use in treating uv-induced skin damage and hyperplasia

Also Published As

Publication number Publication date
EP3194032A4 (en) 2018-05-23
JP2017525738A (ja) 2017-09-07
US20160067194A1 (en) 2016-03-10
WO2016036999A1 (en) 2016-03-10
BR112017004304B1 (pt) 2020-12-08
AU2015311799A1 (en) 2017-03-30
BR112017004304A2 (pt) 2017-12-05
EP3194032A1 (en) 2017-07-26
CN107106877A (zh) 2017-08-29
MX2017002818A (es) 2017-08-02
CA2959756A1 (en) 2016-03-10
US9980924B2 (en) 2018-05-29
MX375612B (es) 2025-03-06
KR20170045343A (ko) 2017-04-26
EP3194032B1 (en) 2021-06-23
CA2959756C (en) 2023-02-28

Similar Documents

Publication Publication Date Title
GB2544342B (en) Compositions for application to wounds
ZA201603314B (en) Nicotinamide riboside compositions for topical use in treating skin conditions
HUE051373T2 (hu) Készítmények MPSI kezelésére
EP3035908A4 (en) Topical skin compositions for treating wrinkles
DK2957282T3 (en) Oral antiseptic composition for treating oral mucositis
IL239921A0 (en) Preparations containing solutions in solid state and their use for the treatment of pain
EP2997961A4 (en) CLEANSER FOR THE SKIN
IL252619B (en) Modified polysaccharides for use in antimicrobial agents
PL2792364T3 (pl) Kompozycja do zapobiegania lub do leczenia kaca
SG11201508879XA (en) Skin cleansing composition
SG2013002687A (en) Anti-microbial composition
SG11201510300RA (en) Compositions and methods for treating skin
ZA201701510B (en) Topical pterostilbene compositions for use in treating uv-induced loss of barrier function in skin
SG11201602573RA (en) Skin cosmetic composition
PL3041831T3 (pl) Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby
IL243759A0 (en) Antiaging skin care product
IL240334A0 (en) Local antifungal preparation for the treatment of nail fungus
SG11201508529RA (en) Skin cleansing composition
SG11201802292UA (en) Composition for treating pain
GB201400647D0 (en) Topical composition
ZA201507015B (en) Composition for treating hemorrhoids
PL3041459T3 (pl) Kompozycje przydatne w zapobieganiu lub leczeniu raka skóry
IL252933A0 (en) Waterless cosmetic preparation for local application
SG11201802551WA (en) Skin disinfectant composition
IL246800A0 (en) Local antifungal preparation for the treatment of nail fungus